Cargando…

Anthocyanin on platelet function in people with dyslipidaemia

Detalles Bibliográficos
Autor principal:	Ogunleye, Ayodele A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601983/ https://www.ncbi.nlm.nih.gov/pubmed/34768085 http://dx.doi.org/10.1016/j.ebiom.2021.103682

Ejemplares similares

The interleukin-1 cluster, dyslipidaemia and risk of myocardial infarction
por: Keavney, Bernard
Publicado: (2010)

Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021)

Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021)

The year in dyslipidaemia 2008 /
Publicado: (2009)

The year in dyslipidaemia 2007
Publicado: (2008)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
por: Iyengar, S. S., et al.
Publicado: (2020)

The year in dyslipidaemia : version en español 2009-2010 /
Publicado: (2010)

Dyslipidaemia in Rheumatological Autoimmune Diseases
por: Toms, Tracey E, et al.
Publicado: (2011)

Angina due to hypertension and dyslipidaemia
por: Fox, Kim
Publicado: (2019)

Nutraceuticals in Paediatric Patients with Dyslipidaemia
por: Banderali, Giuseppe, et al.
Publicado: (2022)

Fixed Combination for the Treatment of Dyslipidaemia
por: Ferri, Nicola, et al.
Publicado: (2023)

The year in dyslipidaemia 2005-2006
Publicado: (2006)

Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)
por: Raal, Frederick J, et al.
Publicado: (2013)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice
por: Penson, Peter E., et al.
Publicado: (2021)

Antiretroviral Therapy and Dyslipidaemia: Unlocking the Code
por: Mallon, Patrick W. G
Publicado: (2006)

Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia
por: Rizzo, Manfredi, et al.
Publicado: (2011)

Adverse effects of the ‘Noakes’ diet on dyslipidaemia
por: Schamroth, C
Publicado: (2014)

Established and Emerging Approaches for the Management of Dyslipidaemia
por: Norata, Giuseppe Danilo
Publicado: (2012)

Pathophysiology of diabetic dyslipidaemia: where are we?
por: Vergès, Bruno
Publicado: (2015)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
por: Agarwala, Anandita, et al.
Publicado: (2020)

HIV: how to manage dyslipidaemia in HIV
por: Lee, Daniel
Publicado: (2022)

Physical activity and breast cancer survival
por: Ogunleye, Adeyemi A, et al.
Publicado: (2009)

Regulation of the mTOR-Rac1 axis in platelet function
por: Aslan, Joseph E., et al.
Publicado: (2012)

Postprandial metabolic heterogeneity in men with primary dyslipidaemia
por: Pavlidis, Antonios N., et al.
Publicado: (2010)

Association of homocysteinaemia with hyperglycaemia, dyslipidaemia, hypertension and obesity
por: Moraba, Mpho, et al.
Publicado: (2013)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Lorenzatti, Alberto J, et al.
Publicado: (2020)

Hypertension and Dyslipidaemia in Argentina: Patient Journey Stages
por: Sadler, Alberto E, et al.
Publicado: (2022)

Statin Therapy and the Assessment of Hepatoprotection in Patients with Dyslipidaemia
por: Beznă, Marinela, et al.
Publicado: (2023)

Present and Future of Dyslipidaemia Treatment—A Review
por: Merćep, Iveta, et al.
Publicado: (2023)

The year in dyslipidaemia 2002,Versión en español/
Publicado: (2002)

Pretransplant dyslipidaemia determines outcome in lung transplant recipients
por: Wenger, Urs, et al.
Publicado: (2013)

The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats
por: Aldini, Giancarlo, et al.
Publicado: (2011)

Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: Systematic review and metaanalysis
por: Osborn, David PJ, et al.
Publicado: (2008)

Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia
por: Koh, Natalie, et al.
Publicado: (2021)

Glucagon-Like Peptide 1 Receptor Activation and Platelet Function: Beyond Glycemic Control
por: Jia, Guanghong, et al.
Publicado: (2016)

Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia
por: Boccara, Franck, et al.
Publicado: (2017)

Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
por: Visser, Jolien, et al.
Publicado: (2022)

Where is Waldo? or find the platelet
por: Menter, D. G.
Publicado: (2021)

Trends in Prevalence of Dyslipidaemias and the Risk of Mortality in Lithuanian Urban Population Aged 45–64 in Relation to the Presence of the Dyslipidaemias and the Other Cardiovascular Risk Factors
por: Luksiene, Dalia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f8it08p8q9kjt8h8shu9u4scn1